79 / 112
77
WFSBP 2015
Thursday, 18 June 2015
|
Scientific Programme
S-56-003
Genetic markers of autism-spectrum disorders
Christos Pantelis, Australia
E. Skafidas, R. Testa, D. Zantomio, G. Chana, I. Everall
S-56-004
Diagnostic and prognostic imaging markers in neurode-
generative disorders
Jessica Peter, Germany
S. Klöppel
T40: S
chizophrenia
: B
asic
/ C
linical
S-57
Symposium
15:00–16:30
Mitropoulos Hall
Central role of glial cells in the pathogenesis of schizo-
phrenia
Chair:
Robert Schwarcz, USA
Co-Chair: Ina Weiner, Israel
S-57-001
Microglia: A common target for diverse drugs preventing
schizophrenia?
Ina Weiner, Israel
S-57-002
Prenatal elevation of the glia-derived neuromodulator
kynurenic acid: A novel schizophrenia model
Robert Schwarcz, USA
A. Pocivavsek
S-57-003
Inflammatory imbalance in the periphery signalled by
kynurenines is correlated with wide-spread grey matter
decreases in people with schizophrenia
Cynthia Shannon Weickert, Australia
K. Zavitsanou, C. K. Lim, G. J. Guillemin, R. Lenroot, J. Kind-
ler, V. Catts, S. Catts, J. Bruggemann, T. Weickert
S-57-004
Astrocytic dopamine modulates neuronal network and
cognitive functions in the prefrontal cortex
Jean-Pierre Mothet, France
T37: P
sychoneuroimmunology
S-58
Symposium
15:00–16:30
Skalkotas Hall
Diagnostic and prognostic stratification of affective dis-
orders based on inflammation biomarkers and immune
related neurotransmitter pathways
Chair:
Angelos Halaris, USA
Co-Chair: Aye-Mu Myint, Germany
S-58-001
Stratification and outcome prediction of depressed patients
using panels of inflammation biomarkers
Angelos Halaris, USA
S-58-002
Can plasma levels of kynurenines assist in the stratification
of mood disorders?
Aye-Mu Myint, Germany
B. Sperner-Unterweger, V. Arolt
S-58-003
Inflammation-induced disturbances of neurotransmitter
precursor amino acids and their possible role as biomarkers
in depression
Barbara Sperner-Unterweger, Austria
K. Hüfner, A. Oberguggenberger, C. Kohl, S. Geisler,
E. Gamper, V. Meraner, J. Egeter, M. Hubalek, B. Beer-Sand-
ner, D. Fuchs
S-58-004
Biomarker and therapeutic potential of the endocannabi-
noid system in neuroinflammation-related psychoses
Rafael Franco, Spain
G. Navarro, I. Reyes-Resina
T40: S
chizophrenia
: B
asic
/ C
linical
S-59
Symposium
15:00–16:30
MC 3 Room
Dysregulation of tyrosine transport influence dopamine
function and cause cognitive deficits in schizophrenia
Chair:
Nikolaos Venizelos, Sweden
Co-Chair: Lenna Flyckt, Sweden
S-59-001
Aberrant tyrosine transport in fibroblast from patients with
schizophrenia and bipolar-I disorders
Nikolaos Venizelos, Sweden
S-59-002
Aberrant tyrosine transport in fibroblast from patients with
schizophrenia–indication of maternal inheritance
Lenna Flyckt, Sweden